Davina McCall reveals she has undergone surgery for breast cancer​Davina McCall reveals she has undergone surgery for breast cancer 

Presenter says she is ‘in a much more positive place’ after having lumpectomy and catching cancer earlyDavina McCall has revealed she has undergone surgery for breast cancer and urged others to “get checked”.In a video posted to Instagram, the presenter said she was “very angry” when she found out about the cancer, but felt in a “much more positive place” after a lumpectomy. Continue reading…

HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model​HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model 

A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast cancer, according to new research published in the November issue of The Journal of Nuclear Medicine. The regimen, which pre-treats the tumor before delivering targeted alpha-radioimmunotherapy, resulted in durable major responses—including histologic cures—with minimal toxicities, paving the way for a safer and more effective treatment option for breast cancer patients.

Hopeful Lipid-Busters to Watch at AHA: New GLP-1, Gene Therapy, Oral PCSK9 Inhibitor​Hopeful Lipid-Busters to Watch at AHA: New GLP-1, Gene Therapy, Oral PCSK9 Inhibitor 

(MedPage Today) — NEW ORLEANS — Innovations in lipid lowering get a major chance to shine, and potentially move the needle in cardiometabolic treatment, this weekend here at the American Heart Association (AHA) annual meeting. Spearheading… ​ (MedPage Today) — NEW ORLEANS — Innovations in lipid lowering get a major chance to shine, and potentially Read More

Does Microdosing GLP-1s Work? Expert Weighs In​Does Microdosing GLP-1s Work? Expert Weighs In 

(MedPage Today) — Welcome to Culture Clinic, MedPage Today’s collaboration with Northwell Health to offer a healthcare professional’s take on the latest viral medical topics. More companies are promoting microdosing GLP-1 receptor agonists even… ​ (MedPage Today) — Welcome to Culture Clinic, MedPage Today’s collaboration with Northwell Health to offer a healthcare professional’s take on Read More

Breast cancer relapse: Key cellular resistance mechanism discovered​Breast cancer relapse: Key cellular resistance mechanism discovered 

Triple-negative breast cancer is one of the most aggressive and difficult cancers to treat. It can initially respond well to therapeutic combinations of chemotherapy, but a tiny minority of tumor cells may manage to tolerate these treatments. These so-called “persister” cells are then able to reform a tumor, causing a relapse of breast cancer in 20 to 30% of cases.